依达拉奉清除自由基机制及临床应用  

Free radical scavenging mechanism of edaravone and its clinical application

作　　者：马利萍[1] 孙建国[1] 彭英[1] 王广基[1] 

机构地区：[1]中国药科大学药物代谢动力学重点实验室

出　　处：《中国临床药理学与治疗学》2011年第3期341-348,共8页Chinese Journal of Clinical Pharmacology and Therapeutics

基　　金：中央高校基本科研业务费专项资助(JKP2009007);"十一五"重大新药创制项目资助(2009ZX09304-001)

摘　　要：研究证实,多种人类疾病的发生与机体过量自由基的产生相关,过量自由基损伤脂质,蛋白质和DNA等生物大分子,导致对机体的有害作用。依达拉奉(edaravone)为强效自由基清除剂,于2001年在日本上市,临床上主要用于治疗急性缺血性脑中风。本文对依达拉奉清除自由基的机制和治疗多种人类疾病的研究进展作简要概述,主要介绍了依达拉奉在治疗脑、心脏等多器官的缺血/再灌注损伤,肌萎缩侧索硬化症(ALS)、帕金森病(PD)、阿尔茨海默病(AD)、多发性硬化症等神经性疾病,癫痫,动脉粥样硬化,肝、肺纤维化病变,类风湿性关节炎和突发性耳聋等多种人类疾病中的应用,为进一步开发依达拉奉在临床上的新用途提供参考。Researches certified that overpro-duction of free radicals has been implicated in many human diseases , as excessive free radicals damage biomacromole cules such as lipids ,pro-tein and DNA , leading to deleterious effect of the body. Edaravone, a potent free radical scav-enger, has been approved in Japan for the treat-ment of acute cerebral infarction since April 2001. This review illustrated the hypothetical free radical scavenging mechanism of edaravone and summarized the research progress of edara-vone in treating many human diseases. The pro- tective effect of edaravone in treating ischemic/reperfusion injury in many organs（brain, heart et al）, neurodegenerative diseases （Amyotrophic Lateral Sclerosis, Parkinson＇s disease, Alzhei-mer＇s disease et al）, epilepsy, atherosclerosis, hepatic fibrosis and pulmonary fibrosis diseases, rheumatoid arthritis and sudden hearing loss are described in this review, which may provide ref-erence for the novel clinical application of edara-vone in future.

关 键 词：依达拉奉 自由基 氧化应激 

分 类 号：R969[医药卫生—药理学]